-
Founded in:
1979-01-01 -
Country:
China -
Address:
No. 352, Laodong East Road, Changzhou -
Tax NO.:
91320400137158984C -
Registered Funds:
25 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clindamycin hydrochloride |
Extract from the above information
More
Extract from the above information |
21462-39-5 | 34 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 6-Aminocaproic acid |
This product is an antifibrinolytic drug that can qualitatively inhibit the binding of plasminogen to fibrin, prevent its activation, and thus inhibit fibrinolysis; high concentrations (100 mg/L) directly inhibit the activity of plasmin and achieve a hemostatic effect.
More
This product is an antifibrinolytic drug that can qualitatively inhibit the binding of plasminogen to fibrin, prevent its activation, and thus inhibit fibrinolysis; high concentrations (100 mg/L) directly inhibit the activity of plasmin and achieve a hemostatic effect. |
60-32-2 | 6 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| L-carnitine |
A natural substance in the body that is essential for mammalian energy metabolism. Its main function is to promote lipid metabolism. In the case of ischemia and hypoxia, it can reduce the accumulation of acyl-CoA, increase the level of free carnitine, maintain the stability of membrane structure, and avoid cell death. It provides energy for muscle cells (especially myocardial cells), brain, kidney and other tissues by accelerating fatty acid oxidation and ATP production. It can also increase the activity of NADH cytochrome reductase and cytochrome oxidase, participate in drug detoxification, and has multiple functions such as medium-chain fatty acid oxidation, fatty acid peroxidase oxidation, buffering coenzyme A ratio, removing excessive coenzyme A toxicity and regulating blood ammonia concentration.
More
A natural substance in the body that is essential for mammalian energy metabolism. Its main function is to promote lipid metabolism. In the case of ischemia and hypoxia, it can reduce the accumulation of acyl-CoA, increase the level of free carnitine, maintain the stability of membrane structure, and avoid cell death. It provides energy for muscle cells (especially myocardial cells), brain, kidney and other tissues by accelerating fatty acid oxidation and ATP production. It can also increase the activity of NADH cytochrome reductase and cytochrome oxidase, participate in drug detoxification, and has multiple functions such as medium-chain fatty acid oxidation, fatty acid peroxidase oxidation, buffering coenzyme A ratio, removing excessive coenzyme A toxicity and regulating blood ammonia concentration. |
541-15-1 | 17 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Midecamycin A1 |
It is a multi-component macrolide antibiotic produced by Streptomyces. Its antibacterial properties are similar to those of erythromycin. It has strong antibacterial effects on Gram-positive bacteria and mycoplasmas, and also has antibacterial effects on some Gram-negative bacteria such as Neisseria meningitidis and Neisseria gonorrhoeae. Some erythromycin-resistant Staphylococcus aureus may still be sensitive to this product. It works by acting on the 50S subunit of the bacterial ribosome, hindering the synthesis of bacterial proteins, and is an antibacterial drug during the growth period.
More
It is a multi-component macrolide antibiotic produced by Streptomyces. Its antibacterial properties are similar to those of erythromycin. It has strong antibacterial effects on Gram-positive bacteria and mycoplasmas, and also has antibacterial effects on some Gram-negative bacteria such as Neisseria meningitidis and Neisseria gonorrhoeae. Some erythromycin-resistant Staphylococcus aureus may still be sensitive to this product. It works by acting on the 50S subunit of the bacterial ribosome, hindering the synthesis of bacterial proteins, and is an antibacterial drug during the growth period. |
0 | ||
| Sineptina A6 |
It is a multi-component macrolide antibiotic produced by Streptomyces. Its antibacterial properties are similar to those of erythromycin. It has strong antibacterial effects on Gram-positive bacteria and mycoplasmas, and also has antibacterial effects on some Gram-negative bacteria such as Neisseria meningitidis and Neisseria gonorrhoeae. Some erythromycin-resistant Staphylococcus aureus may still be sensitive to this product. It works by acting on the 50S subunit of the bacterial ribosome, hindering the synthesis of bacterial proteins, and is an antibacterial drug during the growth period.
More
It is a multi-component macrolide antibiotic produced by Streptomyces. Its antibacterial properties are similar to those of erythromycin. It has strong antibacterial effects on Gram-positive bacteria and mycoplasmas, and also has antibacterial effects on some Gram-negative bacteria such as Neisseria meningitidis and Neisseria gonorrhoeae. Some erythromycin-resistant Staphylococcus aureus may still be sensitive to this product. It works by acting on the 50S subunit of the bacterial ribosome, hindering the synthesis of bacterial proteins, and is an antibacterial drug during the growth period. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Midecamycin A1 |
It is a multi-component macrolide antibiotic produced by Streptomyces, which has strong antibacterial effects on Gram-positive bacteria and mycoplasma, and also has antibacterial effects on some Gram-negative bacteria such as Neisseria meningitidis and Neisseria gonorrhoeae. It works by acting on the 50S subunit of bacterial ribosomes, hindering the synthesis of bacterial proteins, and is an antibacterial drug during the growth period.
More
It is a multi-component macrolide antibiotic produced by Streptomyces, which has strong antibacterial effects on Gram-positive bacteria and mycoplasma, and also has antibacterial effects on some Gram-negative bacteria such as Neisseria meningitidis and Neisseria gonorrhoeae. It works by acting on the 50S subunit of bacterial ribosomes, hindering the synthesis of bacterial proteins, and is an antibacterial drug during the growth period. |
0 | ||
| Sineptina A6 |
It is a multi-component macrolide antibiotic produced by Streptomyces, which has strong antibacterial effects on Gram-positive bacteria and mycoplasma, and also has antibacterial effects on some Gram-negative bacteria such as Neisseria meningitidis and Neisseria gonorrhoeae. It works by acting on the 50S subunit of bacterial ribosomes, hindering the synthesis of bacterial proteins, and is an antibacterial drug during the growth period.
More
It is a multi-component macrolide antibiotic produced by Streptomyces, which has strong antibacterial effects on Gram-positive bacteria and mycoplasma, and also has antibacterial effects on some Gram-negative bacteria such as Neisseria meningitidis and Neisseria gonorrhoeae. It works by acting on the 50S subunit of bacterial ribosomes, hindering the synthesis of bacterial proteins, and is an antibacterial drug during the growth period. |
0 |